Last update 06 Jul 2026

MWX-205

Overview

Basic Info

Drug Type
siRNA
Synonyms
MWX 205, MWX205
Target
ANGPTL3 x PCSK9
Action
inhibitors
Mechanism
ANGPTL3 inhibitors(Angiopoietin like 3 inhibitors), PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors), RNAi(RNA interference)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
HyperlipidemiasDyslipidemias
Inactive Indication-
Originator Organization
Shanghai Minwei Biotechnology Co., Ltd
Active Organization
Shanghai Minwei Biotechnology Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

1
Clinical Trials associated with MWX-205
NCT07634510
/ Not yet recruitingPhase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered MWX205 Injection in Adult Participants With Dyslipidemia
100 Clinical Results associated with MWX-205
Login to view more data
100 Translational Medicine associated with MWX-205
Login to view more data
100 Patents (Medical) associated with MWX-205
Login to view more data
100 Deals associated with MWX-205
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasIND Approval
Australia
Shanghai Minwei Biotechnology Co., Ltd
08 Jun 2026
DyslipidemiasPreclinical
China
Shanghai Minwei Biotechnology Co., Ltd
23 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free